Epidemiology and clinical characteristics of GERD in the Japanese population.
about
Kampo medicines for gastrointestinal tract disorders: a review of basic science and clinical evidence and their future applicationProton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs)Dissociation and dispersion of claudin-3 from the tight junction could be one of the most sensitive indicators of reflux esophagitis in a rat model of the diseaseEvidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.Medical cost, incidence rate, and treatment status of gastroesophageal reflux disease in Japan: analysis of claims data.Therapeutic Response to Twice-daily Rabeprazole on Health-related Quality of Life and Symptoms in Patients with Refractory Reflux Esophagitis: A Multicenter Observational Study.Quality of life in patients with gastroesophageal reflux disease in an Iranian population.Validation of the GerdQ questionnaire for the management of gastro-oesophageal reflux disease in JapanOld age and male sex are associated with increased risk of asymptomatic erosive esophagitis: analysis of data from local health examinations by the Korean National Health Insurance Corporation.Helicobacter pylori infection status had no influence on upper gastrointestinal symptoms: a cross-sectional analysis of 3,005 Japanese subjects without upper gastrointestinal lesions undergoing medical health checkups.Clinical Characteristics of Severe Erosive Esophagitis among Patients with Erosive Esophagitis: A Case-control StudyGastroesophageal Reflux Disease and Helicobacter pylori: What May Be the Relationship?Time Trends of Gastro-esophageal Reflux Disease (GERD) and Peptic Ulcer Disease (PUD) in IranPrevalence and risk factor of erosive esophagitis observed in Korean National Cancer Screening Program.Association between obesity and Barrett's esophagus in a Japanese population: a hospital-based, cross-sectional study.Clinical application of kampo medicine (rikkunshito) for common and/or intractable symptoms of the gastrointestinal tract.Overweight associated with increased risk of erosive esophagitis in a non-obese Taiwanese population.The changing patterns of dispensing branded and generic drugs for the treatment of gastroesophageal reflux disease between 2006 and 2011 in Japan: a retrospective cohort study.Trend in gastric cancer: 35 years of surgical experience in Japan.Lifestyle change influences on GERD in Japan: a study of participants in a health examination program.Acid reflux directly causes sleep disturbances in rat with chronic esophagitisGastroesophageal reflux disease and tooth erosionLong-Term Benefits of Smoking Cessation on Gastroesophageal Reflux Disease and Health-Related Quality of LifeLocalization of specialized intestinal metaplasia and the molecular alterations in Barrett esophagus in a Japanese population: an analysis of biopsy samples based on the "Seattle" biopsy protocol.Recent effectiveness of proton pump inhibitors for severe reflux esophagitis: the first multicenter prospective study in JapanCharacteristics of symptomatic reflux episodes in Japanese proton pump inhibitor-refractory non-erosive reflux disease patients.The daily response for proton pump inhibitor treatment in Japanese reflux esophagitis and non-erosive reflux diseaseArm span-height difference is correlated with gastroesophageal reflux symptoms in aged Japanese subjects.Minimal endoscopic changes in non-erosive reflux disease.Prevalence of gastroesophageal reflux disease symptoms and related factors in patients with rheumatoid arthritisClassification of chronic cough by systematic treatment cascade trial starting with beta agonist.Upper Gastrointestinal Symptoms Are More Frequent in Female than Male Young Healthy Japanese Volunteers as Evaluated by Questionnaire.Background factors of reflux esophagitis and non-erosive reflux disease: a cross-sectional study of 10,837 subjects in Japan.Persistent reflux symptoms cause anxiety, depression, and mental health and sleep disorders in gastroesophageal reflux disease patients.Efficacy of alfacalcidol and alendronate on lumbar bone mineral density in osteoporotic patients using proton pump inhibitors.Is Atrial Fibrillation a Risk Factor for Gastroesophageal Reflux Disease Occurrence?The efficacy and safety of proton-pump inhibitors in treating patients with non-erosive reflux disease: a network meta-analysis.Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis.Liquid-containing Refluxes and Acid Refluxes May Be Less Frequent in the Japanese Population Than in Other Populations: Normal Values of 24- hour Esophageal Impedance and pH Monitoring.Association of medications for lifestyle-related diseases with reflux esophagitis.
P2860
Q26830898-C398859A-4E49-4622-A37C-3A1B2E1FFA59Q28479037-C3B0CB22-B1B0-425C-89B2-2941F16D49F8Q28580941-575FC346-86F5-471D-ADE1-B679A69602DAQ30249468-78479EA7-350A-4B0A-8B1F-DEF072D9B742Q31098671-1726797B-5728-4372-AA67-B81A2BF97448Q32182541-FBE73423-4677-46F0-960A-508160A2A307Q33596579-D4AE2CD9-6E98-43F3-A327-87BD5B82D45DQ33695375-B280579E-E4D0-4014-AC21-6D2FA7046819Q33813924-A2C7B296-7A53-4D7E-977E-60706BAC1E4FQ33840330-4758BE4E-CCDA-47CB-A670-FB382C1D0349Q33874658-D4651FB1-8101-4196-ACE5-E713B7FD865FQ34028410-D8FD2915-820B-4EA7-8391-9E6D3D7D660FQ34134497-8DA28480-C56E-42F3-9085-81FCA12956B2Q34853475-D1E95803-F047-4B9B-A95E-3470F0084E4EQ35000054-22DE7250-A869-4987-A38D-503CAFE9B096Q35030764-5DD3FC24-93E2-4CC0-A8F5-6BE9F203DF92Q35040720-3B0635A1-D8ED-4B85-9EC6-DCBC24850F80Q35149456-BCA20E36-5E5F-4A0E-B0C9-E7CF95AA3E31Q35178076-1F4504A0-1263-4C15-A2D4-CDCE44C26FEFQ35231701-98809442-2471-4558-A64E-5CBA01905364Q35249852-FFD60F59-1D6F-46EC-AA34-FE43DE906DCBQ35614974-22DCEE6C-3358-49F4-AD8F-FB4975E89AACQ35914603-958D0DC3-FEB8-4958-B947-CD61033E28A6Q35986428-8B745449-11D0-4812-8987-D10AF3E06357Q36265354-004959FB-47E5-4011-BAD0-9F94A1551116Q36373664-D2B6F8BA-C59C-459B-8BBA-4BA5E67299A2Q36521933-5140FD89-40D4-4995-AD2C-4359AC749ECAQ36521942-6ACFED99-009E-41A0-98E6-DE88F4435275Q36538275-7F770467-1FC9-4E78-94D8-9A7F0F677957Q36670843-7A01A03A-6FE4-49CE-A803-37F971C1578CQ36698036-16CBED69-C66B-4F3C-B4F7-8A94A5D847BBQ36762643-B11F6E4A-CADF-4E78-8887-9555CAD5A01CQ37048686-47B6B42D-E3DD-484C-911D-CCE789B492BBQ37067053-9D6F15A6-8F21-43EE-9410-1666F88B956EQ37108491-8DEC7765-536F-4A02-8FF0-6262DA12D9F7Q37176387-BD4E1871-F44C-483F-AC60-BC25084B41ACQ37223349-4C216DC9-3567-44B4-8F66-4575ADED0C75Q37238180-65D6F2FC-8F2D-4FD3-B634-1813433B5317Q37324408-F7D0079C-76F9-40AE-BE5F-889DE918750EQ37337245-50CB2DE2-0B77-463B-87C2-B68DDCB19163
P2860
Epidemiology and clinical characteristics of GERD in the Japanese population.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epidemiology and clinical characteristics of GERD in the Japanese population.
@en
Epidemiology and clinical characteristics of GERD in the Japanese population.
@nl
type
label
Epidemiology and clinical characteristics of GERD in the Japanese population.
@en
Epidemiology and clinical characteristics of GERD in the Japanese population.
@nl
prefLabel
Epidemiology and clinical characteristics of GERD in the Japanese population.
@en
Epidemiology and clinical characteristics of GERD in the Japanese population.
@nl
P1476
Epidemiology and clinical characteristics of GERD in the Japanese population.
@en
P2093
Tetsuo Arakawa
Yasuhiro Fujiwara
P304
P356
10.1007/S00535-009-0047-5
P577
2009-04-14T00:00:00Z